Investor Relations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Vital Therapies™ Announces Presentation of ELAD® "Artificial Liver" Data at American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting.
Boston, MA., Nov. 7, 2007 /PRNewswire/- /- Vital Therapies, Inc. (VTI), announced today data from two studies of the company’s ELAD® (Extracorporeal Liver Assist Device) System were presented at the 2007 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, which
View HTML
Toggle Summary ELAD® Liver Support System Study Initiated at Multiple U.S. Center
Program Expands on Successful Results from prior U.S., U.K. and China Trials
View HTML
Toggle Summary Doctors test latest attempt at artificial liver
Doctors test latest attempt at artificial liver
View HTML
Toggle Summary Liver device helps man survive until transplant
Liver device helps man survive until transplant
View HTML
Toggle Summary Vital Therapies Plans Phase III Trials for September
Vital Therapies Plans Phase III Trials for September
View HTML
Toggle Summary Vital new hope for Liver failure
Vital new hope for Liver failure
View HTML
Toggle Summary Vital Therapies Initiates Liver Stabilization Trial
Pivotal ELAD Study in United States and Europe
View HTML
Toggle Summary Bioartificial Human Liver Therapy Trial Progressing
Bioartificial Human Liver Therapy Trial Progressing SAN DIEGO , June 8 /PRNewswire/ -- Vital Therapies, Inc., (VTI) is pleased to announce that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER ( S tabilization I n L i VER failure)
View HTML
Toggle Summary Vital Therapies Expands SILVER Trial to Saudi Arabia
Vital Therapies Expands SILVER Trial to Saudi Arabia
View HTML
Toggle Summary Three-year follow-up data confirm safety and survival benefit in Chinese liver failure patients treated with ELAD®
Three-year follow-up data confirm safety and survival benefit in Chinese liver failure patients treated with ELAD ®
View HTML